The Venture Codex Logo

The Venture Codex

Overview

Investments in cancer-focused data and infrastructure start-ups.

Deals · 12mo

8

Stage focus

Seed
Series A
Series B

Geographic focus

Argentina
Australia
United Kingdom
United States

Sector focus

—

Investment portfolio

12rounds
NAMEDATESIZE
Modicus Prime
May 2026Participated
$5 MOther Equity
Lumonus
Mar 2026Participated
$3 MSeries B
NexCure
Mar 2026Participated
$19 MSeries A
Biomakers
Jan 2026Participated
$8 MSeries A
Risa Labs
Jan 2026Participated
$11 MSeries A
WellBeam
Nov 2025Participated
$10 MSeries A
Lumonus
Nov 2025Participated
$16 MSeries B
IgniteData
Nov 2025Participated
$11 MSeries A
Daymark Health
Sep 2025Participated
$20 MSeries A
Risa Labs
Apr 2025Participated
$4 MSeed
Daymark Health
Apr 2025Participated
$12 MSeed
mPath Health
Oct 2024Led
$1 MSeed
Modicus Prime
May 2026Participated
$5 MOther Equity
Lumonus
Mar 2026Participated
$3 MSeries B
NexCure
Mar 2026Participated
$19 MSeries A
Biomakers
Jan 2026Participated
$8 MSeries A
Risa Labs
Jan 2026Participated
$11 MSeries A
WellBeam
Nov 2025Participated
$10 MSeries A
Lumonus
Nov 2025Participated
$16 MSeries B
IgniteData
Nov 2025Participated
$11 MSeries A
Daymark Health
Sep 2025Participated
$20 MSeries A
Risa Labs
Apr 2025Participated
$4 MSeed
Daymark Health
Apr 2025Participated
$12 MSeed
mPath Health
Oct 2024Led
$1 MSeed
12
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Oncology Ventures: 12 funding rounds are recorded in the selected participation categories.All available history.
Oncology Ventures: 12 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed12
Series A06
Series B02
Other Equity01

Monthly Deal Activity

Oncology Ventures: 12 deals are recorded across 25 months.All available history.
Oncology Ventures: 12 deals are recorded across 25 months. All available history
MonthDeals
Oct '241
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '252
May '250
Jun '250
Jul '250
Aug '250
Sep '251
Oct '250
Nov '253
Dec '250
Jan '262
Feb '260
Mar '262
Apr '260
May '261
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Oncology Ventures: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Oncology Ventures: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Enterprise Software4
AI & Machine Learning3
Space & Frontier Tech1

Deal Size Distribution

Oncology Ventures: 12 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Oncology Ventures: 12 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M4
$5M-$10M1
$10M-$25M7
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Oncology Ventures: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Oncology Ventures: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Australia2
Argentina1
Europe1
Oncology Ventures: 20 co-investors are shown, with Aviron Investment Management sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

Oncology Ventures: Led accounts for 8% and participating for 92% of round participation.All available history.
Oncology Ventures: Led accounts for 8% and participating for 92% of round participation. All available history
CategoryDeals (count)Share (%)
Led18%
Participating1192%
Oncology Ventures: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Oncology Ventures: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Ben Freeberg

Founder and Managing Partner